Nasus Pharma is trading at $3.19 (+6.69%) in after-hours trading following a session with no company-specific catalysts, earnings releases, or late-breaking news.
- The upward move appears tied to broad risk-on sentiment as U.S. equities rallied into the close, with the S&P 500 up 1.46% and the Nasdaq Composite up 2.86%.
- Price action in smaller stocks is often amplified during extended-hours trading due to significantly lower liquidity compared to the regular session.